Compared with Sham mice, CKD mice displayed a significant decrease of epididymal adipose tissue (p < 0.01), and FGF19 treatment did not have any impact on uremic lipodystrophy (Fig. 1G). This evidence concerns the gene FGF19 and chronic kidney disease.